Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models

被引:129
|
作者
Yousefi, Safoora [1 ]
Amrollahi, Fatemeh [1 ]
Amgad, Mohamed [1 ]
Dong, Chengliang [2 ]
Lewis, Joshua E. [3 ,4 ]
Song, Congzheng [5 ]
Gutman, David A. [6 ]
Halani, Sameer H. [4 ]
Vega, Jose Enrique Velazquez [7 ]
Brat, Daniel J. [7 ,8 ]
Cooper, Lee A. D. [1 ,3 ,4 ,8 ]
机构
[1] Emory Univ, Dept Biomed Informat, Sch Med, Atlanta, GA 30322 USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA
[3] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[5] Cornell Univ, Dept Comp Sci, Ithaca, NY 14850 USA
[6] Emory Univ, Dept Neurol, Sch Med, Atlanta, GA 30322 USA
[7] Emory Univ, Dept Pathol & Lab Med, Sch Med, Atlanta, GA 30322 USA
[8] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
美国国家卫生研究院;
关键词
NETWORK; RECURRENCE; SIGNATURE; SUBTYPES;
D O I
10.1038/s41598-017-11817-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Translating the vast data generated by genomic platforms into accurate predictions of clinical outcomes is a fundamental challenge in genomic medicine. Many prediction methods face limitations in learning from the high-dimensional profiles generated by these platforms, and rely on experts to hand-select a small number of features for training prediction models. In this paper, we demonstrate how deep learning and Bayesian optimization methods that have been remarkably successful in general high-dimensional prediction tasks can be adapted to the problem of predicting cancer outcomes. We perform an extensive comparison of Bayesian optimized deep survival models and other state of the art machine learning methods for survival analysis, and describe a framework for interpreting deep survival models using a risk backpropagation technique. Finally, we illustrate that deep survival models can successfully transfer information across diseases to improve prognostic accuracy. We provide an open-source software implementation of this framework called SurvivalNet that enables automatic training, evaluation and interpretation of deep survival models.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models
    Safoora Yousefi
    Fatemeh Amrollahi
    Mohamed Amgad
    Chengliang Dong
    Joshua E. Lewis
    Congzheng Song
    David A. Gutman
    Sameer H. Halani
    Jose Enrique Velazquez Vega
    Daniel J. Brat
    Lee A. D. Cooper
    Scientific Reports, 7
  • [2] An Introduction to Deep Survival Analysis Models for Predicting Time-to-Event Outcomes
    Chen, George H.
    FOUNDATIONS AND TRENDS IN MACHINE LEARNING, 2024, 17 (06): : 921 - 1100
  • [3] An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer
    Hui, Tianli
    Li, Sainan
    Wang, Huimin
    Ma, Xuejiao
    Du, Furong
    Gao, Wei
    Yang, Shan
    Sang, Meixiang
    Li, Ziyi
    Ding, Ran
    Liu, Yueping
    Geng, Cuizhi
    ONCOLOGIST, 2023, : e1160 - e1169
  • [4] Predicting drug response of tumors from integrated genomic profiles by deep neural networks
    Chiu, Yu-Chiao
    Chen, Hung-I Harry
    Zhang, Tinghe
    Zhang, Songyao
    Gorthi, Aparna
    Wang, Li-Ju
    Huang, Yufei
    Chen, Yidong
    BMC MEDICAL GENOMICS, 2019, 12 (Suppl 1)
  • [5] Predicting drug response of tumors from integrated genomic profiles by deep neural networks
    Yu-Chiao Chiu
    Hung-I Harry Chen
    Tinghe Zhang
    Songyao Zhang
    Aparna Gorthi
    Li-Ju Wang
    Yufei Huang
    Yidong Chen
    BMC Medical Genomics, 12
  • [6] Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer
    Fu, Jianfei
    Wu, Lunpo
    Jiang, Mengjie
    Li, Dan
    Jiang, Ting
    Hong, Zhongwu
    Wang, Fan
    Li, Shuguang
    PLOS ONE, 2016, 11 (10):
  • [7] Unified methods for feature selection in large-scale genomic studies with censored survival outcomes
    Spirko-Burns, Lauren
    Devarajan, Karthik
    BIOINFORMATICS, 2020, 36 (11) : 3409 - 3417
  • [8] Correction to: Predicting drug response of tumors from integrated genomic profiles by deep neural networks
    Yu-Chiao Chiu
    Hung-I Harry Chen
    Tinghe Zhang
    Songyao Zhang
    Aparna Gorthi
    Li-Ju Wang
    Yufei Huang
    Yidong Chen
    BMC Medical Genomics, 12
  • [9] PREDICTING ONCOLOGIC SURVIVAL OUTCOMES USING MACHINE LEARNING AND LARGE-SCALE REGISTRY DATA THE BC CANCER REGISTRY EXPERIENCE
    Zhao, Rachel
    Kim, Melodie
    Marwaha, Arshdeep
    Stubbs, Terry
    Sandhu, Prableen
    Narinesingh, Dylan
    Badragan, Iulian
    Proulx, Ryan
    Krauze, Andra
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S56 - S56
  • [10] Evaluating biomarker potential of germline genomic factors for predicting clinical outcomes in prostate cancer
    Zeltser, Nicole
    Houlahan, Kathleen E.
    Al-Hiyari, Sarah M.
    Eng, Stefan E.
    Patel, Yash
    Yamaguchi, Takafumi N.
    Tao, Shu
    Huang, Rong Rong
    Reiter, Robert E.
    Ye, Huihui
    Kinnaird, Adam S.
    Boutros, Paul C.
    CANCER RESEARCH, 2023, 83 (07)